Clinical trial
An Open-label, Randomized, Crossover Study to Investigate the Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers.
NCT06098742 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Randomized, Crossover Study to Investigate the Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers.
- Lead sponsor
- Valenta Pharm JSC
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 25, 2024
- Completion date
- September 20, 2025
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acid-dependent diseases of the gastrointestinal tract, heartburn, symptomatic treatment of gastric and duodenal ulcers